RibeiroPODFT: Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens

Sponsor
Beaver-Visitec International, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT04940793
Collaborator
(none)
46
1
18.2
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as photic phenomena, rotational stability and spectacle independence will be investigated. The follow-up period is 3 months after which vision and refraction should have stabilized.

Condition or Disease Intervention/Treatment Phase
  • Device: POD FT

Detailed Description

This prospective study was performed to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL (PhyslOL, Belgium). Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as rotational stability have been analyzed. The follow-up period was 6 months. All IOL implantations were performed by the investigators Dr. Filomena Ribeiro and Dr. Tiago B Ferreira (Hospital da Luz, Lisboa, Portugal). The study population consists of patients undergoing routine cataract surgery. The study patients underwent binocular implantation of Finevision IOLs depending on the preoperative amount of corneal astigmatism (either a toric POD FT IOL in both eyes or a POD FT in the study eye and a non-toric POD F IOL in the contralateral eye).

Study Design

Study Type:
Observational
Actual Enrollment :
46 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens
Actual Study Start Date :
Jul 18, 2017
Actual Primary Completion Date :
Jan 23, 2019
Actual Study Completion Date :
Jan 23, 2019

Arms and Interventions

Arm Intervention/Treatment
Group 1

Patients indicated for cataract surgery who are candidates for a trifocal IOL implantation and have corneal astigmatism over 1.00 D will be selected for inclusion by the investigators

Device: POD FT
Cataract surgery

Outcome Measures

Primary Outcome Measures

  1. Visual performance [3 Months]

    The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL.

  2. Refractive predictability [3 Months]

    The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL.

Secondary Outcome Measures

  1. Visual performance : predicted and achieved [3 Months]

    The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes will be investigated.

  2. Visual performance at near, intermediate and far distance [3 Months]

    The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL. Visual performance at near, intermediate and far distance will be investigated.

  3. Refractive predictability: photic phenomena [3 Months]

    The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The photic phenomena will be investigated.

  4. Refractive predictability: rotational stability [3 Months]

    The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The rotational stability will be investigated.

  5. Refractive predictability: spectacle independence [3 Months]

    The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The spectacle independence will be investigated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age 21 and older

  • bilateral implantation of a Finevision trifocal diffractive IOL (either a POD FT in both eyes or a POD FT in the study eye and a POD F in the contralateral eye)

  • bilateral cataract surgery with grade 1-4 cataract

  • regular corneal astigmatism of 1.00 D or more before surgery in the study eye

  • previous written informed consent to surgery. Written informed consent to participation in the study and data protection

Exclusion Criteria:
  • relevant concomitant ophthalmic diseases (such as pseudoexfoliation, glaucoma, traumatic cataract and other co-morbidity that could affect capsular bag stability (e.g. Marfan syndrome)

  • irregular corneal astigmatism, any abnormality in corneal topography

  • systemic disease with impact on visual outcome

  • disability to understand and/or fill in patient questionnaires

  • history of other relevant previous ocular surgery (such as corneal surgery, glaucoma surgery, vitreoretinal surgery) which might affect capsular stability or visual outcomes

  • expected residual cylinder ≥ 0.50 D

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital da Luz Lisboa Portugal

Sponsors and Collaborators

  • Beaver-Visitec International, Inc.

Investigators

  • Principal Investigator: Filomena Ribeiro, MD, PhD, FEBO, Hospital da Luz

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beaver-Visitec International, Inc.
ClinicalTrials.gov Identifier:
NCT04940793
Other Study ID Numbers:
  • Ribeiro - POD FT
First Posted:
Jun 28, 2021
Last Update Posted:
Jun 28, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Beaver-Visitec International, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2021